Skip to main content
. 2021 Jun 4;134(13):1593–1601. doi: 10.1097/CM9.0000000000001513

Figure 1.

Figure 1

The treatment and control status of hypertension, diabetes, dyslipidemia, and smoking status in US populations with and without MAFLD. MAFLD: Metabolic associated fatty liver disease.